Ju, Feng, Weng, Jialei, Fan, Ningbo
ORCID: 0000-0002-1622-6747, Wang, Zhefang
ORCID: 0000-0002-2297-2586, Zhou, Chenghui
ORCID: 0000-0003-1170-1761, Zhao, Xinlei, Horstmann, Nellie, Wu, Xiaolin
ORCID: 0009-0006-3037-3328, Hoppe, Sascha, You, Bo
ORCID: 0000-0002-3602-5264, Li, Keying, Duan, Jianxin, Odenthal, Margarete
ORCID: 0000-0002-2424-0960, Hillmer, Axel M.
ORCID: 0000-0002-3381-7266, Quaas, Alexander
ORCID: 0000-0002-3537-6011, Bruns, Christiane J.
ORCID: 0000-0001-6590-8181 and Zhao, Yue
ORCID: 0000-0002-6790-3402
(2025).
AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5.
Cell Death & Disease, 16 (1).
pp. 1-16.
Springer Nature.
ISSN 2041-4889
|
PDF
s41419-025-07773-z.pdf Bereitstellung unter der CC-Lizenz: Creative Commons Attribution. Download (10MB) |
Abstract
[Artikel-Nr.: 483] Esophageal adenocarcinoma (EAC) is the predominant subtype of esophageal cancer (EC) in high-income countries, and radioresistance is one of the key factors for the poor prognosis. In this study, we successfully established a radioresistant EAC in vitro model. Aldo-keto reductase 1C3 (AKR1C3) was identified as a promising regulator of radioresistance by RNA-seq analysis and subsequent functional studies. Through integrated analyses of scRNA-seq and TCGA datasets, we found that AKR1C3 was likely to enhance radioresistance by inhibition of ferroptosis. Indeed, analysis of the lipid ROS level by C11-Bodipy staining and the result of transmission electron microscopy revealed that AKR1C3 could prevent EAC cells from ferroptosis. Mechanistically, AKR1C3 binds to the nucleotide-binding domain of HSPA5, thereby inhibiting the E3 ligase TRIM21-induced ubiquitin-dependent proteasomal degradation of HSPA5, which further stabilizes GPX4, thus inhibiting ferroptosis. Importantly, AKR1C3 inhibitor resensitized the EAC patient-derived organoids to radiotherapy. In conclusion, this study highlights AKR1C3 as a regulator of radioresistance and a potential therapeutic target in EAC.
| Item Type: | Article |
| Creators: | Creators Email ORCID ORCID Put Code Ju, Feng UNSPECIFIED UNSPECIFIED UNSPECIFIED Weng, Jialei UNSPECIFIED UNSPECIFIED UNSPECIFIED Zhao, Xinlei UNSPECIFIED UNSPECIFIED UNSPECIFIED Horstmann, Nellie UNSPECIFIED UNSPECIFIED UNSPECIFIED Hoppe, Sascha UNSPECIFIED UNSPECIFIED UNSPECIFIED Li, Keying UNSPECIFIED UNSPECIFIED UNSPECIFIED Duan, Jianxin UNSPECIFIED UNSPECIFIED UNSPECIFIED |
| URN: | urn:nbn:de:hbz:38-801534 |
| Identification Number: | 10.1038/s41419-025-07773-z |
| Journal or Publication Title: | Cell Death & Disease |
| Volume: | 16 |
| Number: | 1 |
| Page Range: | pp. 1-16 |
| Number of Pages: | 16 |
| Date: | 2 July 2025 |
| Publisher: | Springer Nature |
| ISSN: | 2041-4889 |
| Language: | English |
| Faculty: | Faculty of Medicine |
| Divisions: | Faculty of Medicine > Chirurgie > Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und Transplantationschirurgie |
| Subjects: | Medical sciences Medicine |
| ['eprint_fieldname_oa_funders' not defined]: | Publikationsfonds UzK |
| Refereed: | Yes |
| URI: | http://kups.ub.uni-koeln.de/id/eprint/80153 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
![]() |
View Item |
https://orcid.org/0000-0002-1622-6747